Highlights

Licensed Products in Clinical Trials

Product

Company

Boston Children's Inventor

Clinical Phase

Pomalidomide (multiple indications) Celgene Robert D'Amato, MD, PhD Phase III
Revlimid (various cancer indications) Celgene Robert D'Amato, MD, PhD Phase III
Von Willebrand Factor Baxter Stuart Orkin, MD Phase III
FcRn-Factor VIII and Factor IX Biogen IDEC Wayne Lencer, MD Phase III
Omegaven (Parenteral Nutrition Associated Liver Disease) Fresenius Kabi Mark Puder, MD, PhD Phase II/III
Neo-Urinary Conduit(TM) Tengion Anthony Atala, MD Phase I
dmPGE2 Fate Therapeutics Leonard Zon, MD Phase II
IgF-I Premacure Lois Smith, MD, PhD Phase II
Autism Gene Expression Diagnostic SynapDX Louis Kunkel, PhD and Issac Kohane, MD, PhD Phase I
Children's HospitalTerms and Conditions
Site Designed and Developed by Genuine